PROCEPT BioRobotics Corporation (PRCT)
NGM · Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Peers in Medical Devices
All in industry →Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
Edwards Lifesciences Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.
Recent press releases
April 2026
PROCEPT votes on directors, auditor, and executive compensation at 2026 meeting
# 📜 What This Document Is 📄 This document is a Proxy Statement (Form DEF 14A). Think of it like a formal instruction manual for an Annual Meeting of Stockholders. It doesn't report on quarterly earnings, but rather informs shareholders about the foundational rules and decisions of the company. It
SEC filings
All filings →Insider trades
All insider trades →PROCEPT BioRobotics Corporation has no reported insider trades in the last 90 days.